Skip to content

Predictive Value of Inflammatory Biomarkers and FEV1 for COPD

Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV1 for COPD in Chinese Population - a Prospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03532893
Acronym
PIFCOPD
Enrollment
10385
Registered
2018-05-22
Start date
2018-03-03
Completion date
2021-10-09
Last updated
2022-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, FEV1

Keywords

COPD incidence, Decline in FEV1, Inflammatory biomarkers, EBC, microRNA-23a

Brief summary

This is a multi-center, prospective, cohort study. A total of 10,000 people aged 40~75 without lung disease will be recruited and followed for 3 years. By measure the rate of decline in forced expiratory volume at one second(FEV1) and baseline inflammatory biomarkers in exhaled breath condensate and peripheral blood, we aim to explore the predictive model for chronic obstructive pulmonary disease(COPD) in China.

Detailed description

This is a multi-center, prospective, cohort study. A total of 10,000 subjects aged 40~75 without history of lung disease will be recruited and followed for 3 years. The Department of Respiratory and Critical Care of Peking University First Hospital is responsible for this research. Other 9 units participating in the study, include the The Second Hospital of Hebei Medical University, Henan Provincial People's Hospital, The Second Hospital of Jilin University, The First Affiliated Hospital of Xi'an Jiaotong University, Shandong Provincial Hospital Affiliated to Shandong University,Shanxi Dayi Hospital, Tianjin Medical University General Hospital, The Affiliated Hospital of Inner Mongolia Medical University,The First Hospital of Qinhuangdao. Some questionnaire such as St George's Respiratory Questionnaire (SGRQ), income class, educational level, comorbidity, smoking habit and biomass smoke exposure history will be collected. The baseline level of Interleukin 6 (IL-6), high-sensitivity C-reactive Protein (hs-CRP), microRNAs-23a (miR-23a) in peripheral blood and pH value in exhaled breath condensate (EBC) will be measured, lung spirometry will be tested in the first, second and fourth years. Primary outcome is the incidence of COPD, multivariate regression analysis will be used to establish the predictive model for COPD in China. The study protocol has been approved by the Peking University First Hospital Institutional Review Board (IRB) (2018-31). Any protocol modifications will be submitted for the IRB review and approval.

Interventions

OTHERNo intervention

This is a multi-center,observational, prospective, cohort study. A total of 10,000 subjects aged 40~75 without history of lung disease will be recruited and followed for 3 years. So there is no intervention in this study.

Sponsors

The Second Hospital of Hebei Medical University
CollaboratorOTHER
Henan Provincial People's Hospital
CollaboratorOTHER
Second Hospital of Jilin University
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
Shandong Provincial Hospital
CollaboratorOTHER_GOV
Shanxi Dayi Hospital
CollaboratorOTHER
Tianjin Medical University General Hospital
CollaboratorOTHER
The Affiliated Hospital of Inner Mongolia Medical University
CollaboratorOTHER
The First Hospital of Qinhuangdao
CollaboratorOTHER_GOV
Peking University First Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. aged at 40-75 years old; 2. FEV1/FVC\>70% after inhaled bronchodilator 3. have willing to participate in this study, follow the research program and have the ability to sign the informed consent; 4. lived in a community for more than 1 years and has no plans to move out in the next 4 years 5. can be contacted

Exclusion criteria

1. history of asthma, COPD, lung cancer, active pulmonary tuberculosis, bronchiectasis, diffuse lung disease (interstitial pneumonia, pulmonary sarcoidosis, occupational lung disease, sarcoidosis et al) and pleural disease; 2. history of lobectomy and / or lung transplantation; 3. predicted life expectancy less than 3 years; 4. history of severe psychiatric illnesses, mental disorders, neurological disorders, malignant tumors, chronic liver disease, heart failure, autoimmune diseases, chronic kidney disease; 5. Alcoholism, drug abuse or abuse of toxic solvents; 6. Cannot finish long term follow-up or poor compliance; 7. Do not provide consent

Design outcomes

Primary

MeasureTime frameDescription
The incidence of COPD in the second and fourth year and the association between incidence of COPD and rapid decline of FEV1.4 yearsFEV1/FVC(forced vital capacity)\<70% (after bronchial dilation test);Detect the decline of FEV1(%)by Vitalograph COPD6.

Secondary

MeasureTime frameDescription
The association between incidence of COPD and different comorbidity condition, such as metabolic syndrome, cardiovascular disease.4 yearsRecord comorbidity condition data of human subjects, and then analyze the correlation between the COPD incidence and different comorbidity condition.
The mean decline rate of FEV14 yearsMonitor pulmonary function decline in the second and the fourth year, then calculate the mean decline value.
The correlation between the incidence of COPD and serum IL-6 level.4 yearsDetect the serum IL-6 levels(ng/L), then analyze the correlation between the IL-6 levels and COPD incidence.
The correlation between the incidence of COPD and serum hs-CRP level.4 yearsDetect the serum hs-CRP levels(ng/L), then analyze the correlation between the hs-CRP levels and COPD incidence.
The association between incidence of COPD and the air pollution level in different provinces in China.4 yearsRecord data of air pollution in different provinces in China from the environmental monitoring website. And analyze the correlation between the COPD incidence and air pollution level.
The association between the pH value of EBC and COPD incidence.4 yearsDetect the EBC pH value, then analyze the correlation between the EBC pH value and COPD incidence.
The association between serum miR-23a level and COPD incidence.4 yearsDetect the serum miR-23a level, then analyze the correlation between serum miR-23a level and COPD incidence.
The association between incidence of COPD and other factors.4 yearsThe association between incidence of COPD and other factors (smoking habit, biomass exposure history, eating habit and incoming class).The incidence of COPD in the second and fourth year and the association between incidence of COPD and other factors (smoking habit(has or does not, if has: accumulative total smoking amount), biomass exposure history(yes or no), eating habit(light or greasy) and incoming class(family income per capita \>¥4500, or not)).
The association between decline rate of FEV1 and air pollution level4 yearsRecord data of air pollution in different provinces in China from the environmental monitoring website. And analyze the correlation between the decline rate of FEV1 and air pollution level.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026